Key Financial Inc’s Collegium Pharmaceutical COLL Stock Holding History

Key Financial Inc’s Portfolio COLL Stock Details COLL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$6.52K	Hold	180	–	–	﹤0.01%	964
2026 Q1	$5.95K	Hold	180	–	–	﹤0.01%	998
2025 Q4	$8.33K	Hold	180	–	–	﹤0.01%	926
2025 Q3	$6.33K	Hold	180	–	–	﹤0.01%	986
2025 Q2	$5.32K	Hold	180	–	–	﹤0.01%	1016
2025 Q1	$5.37K	Hold	180	–	–	﹤0.01%	979
2024 Q4	$5.16K	Hold	180	–	–	﹤0.01%	982
2024 Q3	$6.96K	Hold	180	–	–	﹤0.01%	885
2024 Q2	$5.8K	Hold	180	–	–	﹤0.01%	922
2024 Q1	$6.99K	Hold	180	–	–	﹤0.01%	849
2023 Q4	$5.54K	Hold	180	–	–	﹤0.01%	894
2023 Q3	$4.02K	Hold	180	–	–	﹤0.01%	981
2023 Q2	$3.87K	Buy	+180	New	+$4.09K	﹤0.01%	1027

Other funds holding COLL

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Jupiter Topco New York $245B AUM

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

EAM

Eventide Asset Management Boston, Massachusetts $7.48B AUM 104.76% 1-Year Est. Return

Key Financial Inc's COLL Position: Q2 2026 in Review

Key Financial Inc held its Collegium Pharmaceutical (COLL) position steady in Q2 2026 at 180 shares worth $6.52K. The position accounts for ﹤0.01% of the portfolio, ranked #964.

Key Financial Inc first reported a position in COLL in Q2 2023 and has held it in 13 quarters since. The position peaked at $8.33K in Q4 2025. 279 funds tracked by Wall St. Rank hold COLL as of Q2 2026.

Key Financial Inc held 180 shares of Collegium Pharmaceutical worth $6.52K as of Q2 2026.
Key Financial Inc left its Collegium Pharmaceutical share count unchanged in Q2 2026.
Collegium Pharmaceutical made up ﹤0.01% of Key Financial Inc's portfolio in Q2 2026, its #964 holding.
Key Financial Inc first reported a position in Collegium Pharmaceutical in Q2 2023 and has held it in 13 quarters since.
Key Financial Inc's Collegium Pharmaceutical position peaked at $8.33K in Q4 2025.
279 funds tracked by Wall St. Rank held Collegium Pharmaceutical as of Q2 2026.

Based on Key Financial Inc's 13F filing for Q2 2026, filed 24 Jul 2026.